Improving breast and cervical cancer screening in Kenya
Official title: Enhanced BReast and cErvical cAncer screening in Kenya THROUGH implementation science research and training (The BREAKTHROUGH Center)
Funded at Emory University · NIH-10931592 · Data updated 2026-11-12
This study is working to make it easier for women in Kenya to get screened and treated for breast and cervical cancers by training healthcare providers and improving how screening and treatment are connected, so that more women can catch these cancers early and get the help they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $923,269 |
| NIH project number | 5U54CA284036-02 |
| Project ID | NIH-10931592 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women in Kenya who are at risk for breast and cervical cancers and have limited access to screening and treatment services.
✕Less likely to help
Patients outside of Kenya or those who do not have risk factors for breast and cervical cancers may not benefit from this research.
What this research studies
This research aims to enhance the screening and treatment of breast and cervical cancers in Kenya by addressing the gaps in healthcare access and implementation of existing knowledge. It involves collaboration among multiple institutions, including Kenyatta National Hospital and Emory University, to engage community and clinical stakeholders in developing effective strategies. The project will focus on training healthcare providers and improving the linkage between screening and treatment to reduce late-stage cancer presentations. Through a comprehensive approach, the research seeks to create sustainable practices that can be adopted in sub-Saharan Africa.
Why it matters
Potential benefit: If successful, this research could significantly reduce the morbidity and mortality associated with breast and cervical cancers in Kenya.
How similar studies have gone: Previous research has shown success in improving cancer screening rates through community engagement and training, indicating that this approach has potential for positive outcomes.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Chung, Michael Hoonbae — Emory University
- Study coordinator: Chung, Michael Hoonbae
Related research
Other NIH-funded projects on the same topics.
-
Enhanced breast and cervical cancer screening in Kenya through implementation science and training
A multi-institution effort to boost breast and cervical cancer screening, follow-up, and treatment in Kenya using hands-on implementation science and training.
-
Enhanced breast and cervical cancer screening in Kenya through implementation science and training
A Breakthrough center project in Kenya aims to improve breast and cervical cancer screening, follow-up, and treatment through real-world implementation approaches and training.
-
Improving breast and cervical cancer screening in Kenya
This project partners with Kenyan hospitals, clinics, and communities to make it easier for people to get breast and cervical cancer screening and timely follow-up care.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
HOPE-inG: Increasing cervical cancer screening for women with HIV in Ghana
A study tests a home-based HPV self-sampling approach plus a tailored communication plan to help women living with HIV in Ghana get screened more often for cervical cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.